ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04510	Focal adhesion	7/34	240/7206	0.000103758758933
ko04512	ECM-receptor interaction	4/34	79/7206	0.000483381701399
ko05100	Bacterial invasion of epithelial cells	4/34	99/7206	0.00113305192226
ko04060	Cytokine-cytokine receptor interaction	5/34	191/7206	0.001848668604
ko05160	Hepatitis C	4/34	153/7206	0.00552061843499
ko04810	Regulation of actin cytoskeleton	5/34	264/7206	0.00740034181243
ko05164	Influenza A	4/34	167/7206	0.00750510423227
ko04068	FoxO signaling pathway	4/34	167/7206	0.00750510423227
ko05205	Proteoglycans in cancer	5/34	271/7206	0.00824642314681
ko05222	Small cell lung cancer	3/34	89/7206	0.00826619162562
ko04151	PI3K-Akt signaling pathway	6/34	390/7206	0.00894548725714
ko04210	Apoptosis	4/34	180/7206	0.00972741718906
ko04932	Non-alcoholic fatty liver disease (NAFLD)	4/34	182/7206	0.0101035622992
ko04064	NF-kappa B signaling pathway	3/34	96/7206	0.0101697285569
ko05202	Transcriptional misregulation in cancer	4/34	188/7206	0.0112887513804
ko05410	Hypertrophic cardiomyopathy (HCM)	3/34	100/7206	0.0113630182229
ko01521	EGFR tyrosine kinase inhibitor resistance	3/34	106/7206	0.0132994923781
ko04012	ErbB signaling pathway	3/34	109/7206	0.0143344206872
ko04668	TNF signaling pathway	3/34	120/7206	0.0185146605072
ko01522	Endocrine resistance	3/34	124/7206	0.0201862577374
ko04215	Apoptosis - multiple species	2/34	47/7206	0.0204587453009
ko05145	Toxoplasmosis	3/34	126/7206	0.0210525352143
ko04931	Insulin resistance	3/34	137/7206	0.0261812627915
ko05213	Endometrial cancer	2/34	62/7206	0.0342534043853
ko05223	Non-small cell lung cancer	2/34	66/7206	0.0384039610667
ko04152	AMPK signaling pathway	3/34	161/7206	0.0395047642817
ko04214	Apoptosis - fly	2/34	72/7206	0.044970283142
ko04910	Insulin signaling pathway	3/34	172/7206	0.0465749766745
ko05418	Fluid shear stress and atherosclerosis	3/34	173/7206	0.0472471775867
ko05224	Breast cancer	3/34	174/7206	0.0479242429227